Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Hidemi, Mochizuki"'
Autor:
Thanyavi Chinsuwan, Koichi Hirabayashi, Shuji Mishima, Aiko Hasegawa, Miyuki Tanaka, Hidemi Mochizuki, Akihito Shimoi, Takashi Murakami, Shigeki Yagyu, Kimihiro Shimizu, Yozo Nakazawa
Publikováno v:
Molecular Therapy: Oncolytics, Vol 31, Iss , Pp 100735- (2023)
Externí odkaz:
https://doaj.org/article/ffeb3c54d64542cca5c3287e7e133003
Autor:
Shigeki Yagyu, Hidemi Mochizuki, Kumiko Yamashima, Hiroshi Kubo, Shoji Saito, Miyuki Tanaka, Kengo Sakamoto, Akihito Shimoi, Yozo Nakazawa
Publikováno v:
Clinical & Translational Immunology, Vol 10, Iss 6, Pp n/a-n/a (2021)
Abstract Objectives Chimeric antigen receptor (CAR)‐T cell therapy possesses the potential to cause unexpected on‐target toxicities that may be life‐threatening. Non‐human primates (NHPs) share considerable structural homology and expression
Externí odkaz:
https://doaj.org/article/31a8621644ab4b998d2df168585d13d6
Publikováno v:
Journal of pharmacological and toxicological methods. 119
Histamine is strongly associated with the onset of allergic conjunctivitis. The most recent cloned histamine H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae44ba377fd52261ed6b262d9dcf4a77
https://pubmed.ncbi.nlm.nih.gov/35842185
https://pubmed.ncbi.nlm.nih.gov/35842185
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 119:107203
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::163d0a63ad1bc8ced6701be2b630ebe2
https://doi.org/10.1016/j.vascn.2022.107203
https://doi.org/10.1016/j.vascn.2022.107203
Autor:
Hidemi Mochizuki1 h-mochizuki@ina-research.co.jp, Naoya Murota1, Shin-ichi Sato1, Kazuo Nii2, Yoko Kouhei2, Masahiro Taniguchi2, Ryo Inoue3, Chiyoko Nishime3, Hideki Tsutsumi3
Publikováno v:
Journal of Toxicological Sciences. 2018, Vol. 43 Issue 11, p685-695. 11p.
Autor:
Hidemi Mochizuki, Miyuki Tanaka, Shigeki Yagyu, Kumiko Yamashima, Shoji Saito, Hiroshi Kubo, Akihito Shimoi, Kengo Sakamoto, Yozo Nakazawa
Publikováno v:
Clinical & Translational Immunology
Clinical & Translational Immunology, Vol 10, Iss 6, Pp n/a-n/a (2021)
Clinical & Translational Immunology, Vol 10, Iss 6, Pp n/a-n/a (2021)
Objectives Chimeric antigen receptor (CAR)‐T cell therapy possesses the potential to cause unexpected on‐target toxicities that may be life‐threatening. Non‐human primates (NHPs) share considerable structural homology and expression profiles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e960b13522e808b97b8b53034488e77
https://pubmed.ncbi.nlm.nih.gov/34123382
https://pubmed.ncbi.nlm.nih.gov/34123382
Autor:
Yoji Sato, Masato Nagaoka, Mitsuhide Ogawa, Takuya Kuroda, Takeshi Watanabe, Hidemi Mochizuki, Eri Kikkawa, Hatsue Furukawa, Shinji Kusakawa, Satoshi Yasuda, Mayumi Futamura
Publikováno v:
Cytotherapy. 23(2)
MEASURE (Multisite Evaluation Study on Analytical Methods for Non-clinical Safety Assessment of HUman-derived REgenerative Medical Products) is a Japanese experimental public-private partnership initiative, which aims to standardize methodology for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecf613de6a46c4804f2a14f65aac8eb6
https://pubmed.ncbi.nlm.nih.gov/32978066
https://pubmed.ncbi.nlm.nih.gov/32978066
Autor:
Hirokazu Morokawa, Miyuki Tanaka, Yozo Nakazawa, Hidemi Mochizuki, Kengo Sakamoto, Shoji Saito, Shigeki Yagyu, Aiko Hasegawa, Akihito Shimoi
Publikováno v:
Clinical & Translational Immunology. 9
Objectives Chimeric antigen receptor (CAR)-T cell therapy redirected to specific antigens on tumor cells is a promising immunotherapy strategy for various cancers. Most target antigens are also expressed on normal tissues at varying levels, and there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da380c18c6285941f20fd286cac20e29
https://doi.org/10.1002/cti2.1207
https://doi.org/10.1002/cti2.1207
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 113:107133
Allergic conjunctivitis is one of the most common immune diseases in the field of ophthalmology. The number of patients suffering from allergic conjunctivitis has been increasing, and there is still a strong need for development of therapeutic agents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1681edbd25b7a4b22f2f57f2207b3fcd
https://doi.org/10.1016/j.vascn.2021.107133
https://doi.org/10.1016/j.vascn.2021.107133
Autor:
Shin-Ichi Sato, Naoya Murota, Masahiro Taniguchi, Yoko Kouhei, Chiyoko Nishime, Kazuo Nii, Hidemi Mochizuki, Ryo Inoue, Hideki Tsutsumi
Publikováno v:
The Journal of toxicological sciences. 43(11)
We investigated the viability of a combined repeated dose toxicity study, including toxicokinetics (TK), in common marmosets according to the ICH-S4, ICH-S3A and ICH-S7A Guidelines using valsartan as test article whose non-clinical repeated dose toxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f31c68fda2e68ab559c8b37b1a5137c
https://pubmed.ncbi.nlm.nih.gov/30405001
https://pubmed.ncbi.nlm.nih.gov/30405001